Guided Therapeutics (GTHP) Cash from Investing Activities (2011 - 2022)
Guided Therapeutics (GTHP) posted Cash from Investing Activities of -$3000.0 for Q4 2022, up 78.57% sequentially from -$14000.0 in Q1 2022, and up 25.0% YoY from -$2400.0 in Q4 2021.
Guided Therapeutics (GTHP) Cash from Investing Activities (2011 - 2022) Analysis & Trends
Guided Therapeutics has reported Cash from Investing Activities for 8 years, with the latest figure at -$3000.0 in Q4 2022.
- Quarterly Cash from Investing Activities rose 25.0% year-over-year to -$3000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2025 was -$3000.0 (up 82.35% YoY) and the FY2025 annual result came in at -$2000.0, changed N/A from the prior year.
- Cash from Investing Activities rose to -$3000.0 in Q4 2022 per GTHP's latest filing, from -$14000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$1000.0 in Q3 2020 and troughed at -$14000.0 in Q1 2022.
- A 3-year average of -$4571.4 and a median of -$4000.0 in 2021 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 25.0% in 2022, down 1300.0% in 2022.
- Over 3 years, Cash from Investing Activities stood at -$1000.0 in 2020, then slumped by 300.0% to -$4000.0 in 2021, then climbed by 25.0% to -$3000.0 in 2022.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3000.0, -$14000.0, and -$4000.0 for Q4 2022, Q1 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Mar 31, 2022 | -14,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Dec 31, 2014 | -6,000.00 |
| Dec 31, 2014 | -6,000.00 |